Ingenuflex
Natural health product licensed in Canada
- Other names
- Ingenuflex Arthri+
- Licence holder
- 7288484 Canada Inc.
- NPN or DIN-HM
- 80044662
- Status
- Active licence
- Licence date
- 11 September 2013
- Revision date
- Not provided
- Form
- Liquide
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Benzoate de sodium, Saveur, Sorbate de potassium, Eau purifiée, Acide chlorhydrique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 10 mL | 1 day |
Uses authorised in Canada
Contribue au maintien d'un cartilage sain. Aide à maintenir le cartilage sain. Contribue au maintien d'articulations saines. Aide à maintenir la santé des articulations.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Si vous êtes enceinte ou si vous allaitez, consultez un praticien de soins de santé avant d'en faire l'usage. Si les symptômes s'aggravent, consulter un praticien de soins de santé. Si vous prenez des anticoagulants, consulter un praticien de soins de santé avant d'en faire l'usage.
- Effets indésirables connus
Peut causer des douleurs abdominales, des ballonnements, de la constipation, de l'indigestion, et/ou de la diarrhée.
Source
Official Health Canada record, licence 80044662
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.